UAMS basic/translational scientists transcribe cutting-edge research into new identification, treatment, and prevention of cancer, infectious disease, substance abuse and behavioral problems. Researchers work with the American Heart/Stroke Associations, Centers for Disease Control, Dept. of Defense, Food and Drug Administration, National Institutes of Health, National Science Foundation, and other national/international organizations to better the health of Arkansans.

UAMS Research News

  • Researchers at UAMS and the University of Arkansas, Fayetteville, are working to develop longer-lasting artificial hip and knee replacement joints that are also more resistant to infections. UAMS’ Mark Smeltzer, Ph.D., a microbiologist with expertise in Staphylococcus aureus and orthopaedic infection, is collaborating with UAF’s Min Zou, Ph.D., a mechanical engineer with expertise in nano-surface-engineering…

  • New grant funding will assist UAMS physician-scientist Analiz Rodriguez, M.D., Ph.D., in identifying more effective therapies for patients whose cancer has spread to their brain.

  • LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…

Want to read more stories like these? Visit the Research News archive.